Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 7 of the 20 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To assess the effectiveness of structured blood glucose testing in poorly controlled, noninsulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: This 12-month, prospective, cluster-randomized, multicenter study recruited 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetic subjects from 34 primary care practices in the U.S. Practices were randomized to an active control group (ACG) with enhanced usual care or a structured testing group (STG) with enhanced usual care and at least quarterly use of structured self-monitoring of blood glucose (SMBG). STG patients and physicians were trained to use a paper tool to collect/interpret 7-point glucose profiles over 3 consecutive days. The primary end point was A1C level measured at 12 months. RESULTS: The 12-month intent-to-treat analysis (ACG, n = 227; STG, n = 256) showed significantly greater reductions in mean (SE) A1C in the STG compared with the ACG: −1.2% (0.09) vs. −0.9% (0.10); Δ = −0.3%; P = 0.04. Per protocol analysis (ACG, n = 161; STG, n = 130) showed even greater mean (SE) A1C reductions in the STG compared with the ACG: −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003. Significantly more STG patients received a treatment change recommendation at the month 1 visit compared with ACG patients, regardless of the patient’s initial baseline A1C level: 179 (75.5%) vs. 61 (28.0%); <0.0001. Both STG and ACG patients displayed significant (P < 0.0001) improvements in general well-being (GWB). CONCLUSIONS: Appropriate use of structured SMBG significantly improves glycemic control and facilitates more timely/aggressive treatment changes in noninsulin-treated type 2 diabetes without decreasing GWB.
Overview
CoChat Summary
TL;DR
In poorly controlled, insulin-naïve type 2 diabetes, structured self-monitoring of blood glucose (SMBG) plus enhanced usual care reduced A1C significantly more than enhanced usual care alone over 12 months. It also produced more timely treatment changes without decreasing general well-being.
Key findings
- In the intent-to-treat analysis (ACG n = 227; STG n = 256), mean (SE) A1C reductions were −1.2% (0.09) for STG vs. −0.9% (0.10) for ACG; Δ = −0.3%; P = 0.04. Per-protocol reductions were −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003.
- Significantly more STG patients received a treatment change recommendation at month 1: 179 (75.5%) vs. 61 (28.0%); P < 0.0001. Mean (SD) scheduled visits with a treatment change recommendation were 2.7 (1.5) vs. 1.1 (1.0); P < 0.0001. More STG patients started intermediate- or long-acting insulin: 42 vs. 23; P = 0.046.
- STG subjects showed reduced preprandial-to-postprandial glucose excursions from month 1 to month 12: breakfast 44 to 35 mg/dL (P < 0.005), lunch 25 to 17 mg/dL (P < 0.03), supper 34 to 26 mg/dL (P < 0.05). Mean amplitude of glucose excursions fell from 38.5 (0.9) to 34.3 (1.0) mg/dL (P = 0.0003).
- General well-being improved in both groups (ACG P < 0.007; STG P < 0.0001), with no significant between-group difference over time; per-protocol adherent STG subjects had greater improvement than adherent ACG subjects (P < 0.04).
Methods
- 12-month prospective, cluster-randomized, multicenter study in 34 U.S. primary care practices randomized to active control (ACG, n = 13 practices) or structured testing (STG, n = 21 practices); 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetes patients were included in the intent-to-treat cohort (ACG n = 227; STG n = 256).
- STG patients and physicians used the Accu-Chek 360° View tool to collect/interpret 7-point glucose profiles over 3 consecutive days before scheduled visits; ACG received enhanced usual care only. Primary endpoint was A1C at 12 months.
- Linear mixed models compared groups over time, controlling for baseline A1C, age, gender, and race as fixed effects and practice site and subject as random effects; intent-to-treat and per-protocol analyses were performed.
Limitations
- Stated: no third study arm assessed the effect of increased attention in both groups; the study could not determine whether treatment changes were clinically appropriate, because it measured number rather than type of change; it could not determine how many recommended changes actually occurred; and STG had greater attrition than ACG (not statistically significant), possibly reflecting intervention burden and biasing findings.
- Evident from the text: the ACG received enhanced usual care, free meters/strips, and more frequent visits, so between-group differences may be conservative; per-protocol results depend on adherence definitions and exclusion of nonadherent STG patients, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
4 Valid · 1 Not valid · 4 Not checked · 51 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Inconsistent findings seen in studies of insulin-naïve type 2 diabetic patients may be due, in part, to differences in key design issues, such as subject selection criteria (e.g., whether or not patients had poor glycemic control at study entry), critical content differences in the actual SMBG intervention (e.g., whether physicians were privy to patient SMBG data), fidelity of treatment delivery (”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > Abstract > CONCLUSIONS
What the sources say
- Supportedcites [14] Polonsky, 2010, The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986], BMC Fam Pract source
The Background summary says that differences in SMBG protocols and study designs have left findings in insulin-naïve type 2 diabetes unclear. Its sections on baseline HbA1c, HCP use of SMBG data, and completion of the prescribed protocol address subject selection, intervention content and delivery, and adherence. Page numbers are not available in our copy. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Measurements of mean amplitude of glucose excursions indicated significant (P = 0.0003) mean (SE) reductions in glycemic variability among STG subjects from 38.5 mg/dL (0.9) at month 1 to 34.3 mg/dL (1.0) at month 12.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no changes in these findings when insulin-using patients were excluded from the analyses.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PP analyses revealed that adherent STG subjects reported a significantly greater improvement in GWB than adherent ACG subjects (P < 0.04).”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > General well-being
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar between-group differences occurred using last observation carried forward analysis (last A1C before insulin start carried forward): −1.0% (0.10) vs. −0.7% (0.10); Δ = −0.3%; P = 0.03.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Changes in treatment
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
25 more claims
Create a free account to see all 60 claims and to verify the 2 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“per protocol analysis of the STeP study showed a significant between-group difference, favoring sSMBG, for general emotional well-being (WHO-5), regimen-related diabetes distress (DDS subscale), and diabetes-specific self-efficacy (CIDS) (61, 62, 64).”
From The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis (2023) · cites this paper as [61]
Experimental — accuracy not yet measuredIn the citing paper
“In a year-long study of insulin-naive people with diabetes with suboptimal initial glycemic outcomes, a group trained in structured BGM (a paper tool was used at least quarterly to collect and interpret seven-point BGM profiles taken on three consecutive days) reduced their A1C levels by 0.3% more than the control group (32).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [32]
In the citing paper
“To optimally benefit from structured SMBG, the obtained BG values therefore have to be actively used by PwD or healthcare professionals (HCPs) for therapeutic decisions or therapy adjustments, such as changes in eating behavior, lifestyle and/or anti-diabetic therapy [9].”
From Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) · cites this paper as [9]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Bech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.145 · Cited by 1,015 · cited 1×
“GWBwas measured using theWHO-5 Well-Being Index assessment tool (17), a widely used, five-item questionnaire with a total score range of from 0–100 (higher scores indicatingmorepositivewell-being).”
Method(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Cited by
Items 101–200 of 426
Polonsky, W. H., Fisher, L., Hessler, D., & Edelman, S. V. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.599838 · Cited by 42
Self-citationAdapting Medication for Type 2 Diabetes to a Low Carbohydrate Diet
Cucuzzella, M. T., Riley, K., & Isaacs, D. M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.688540 · Cited by 47
Alshehri, M. M., Alothman, S. A., Alenazi, A. M., Rucker, J. L., Phadnis, M. A., Miles, J. M., Siengsukon, C. F., & Kluding, P. M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00612-6 · Cited by 41
Wang, X., Luo, J.-F., Qi, L., Long, Q., Guo, J., & Wang, H.-H. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s211668 · Cited by 37
Leveraging advances in diabetes technologies in primary care: a narrative review
Bode, B. W., King, A., Russell-Jones, D. L., & Billings, L. K. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1931427 · Cited by 46
Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
Kim, E. K., Kwak, S. H., Baek, S., Lee, S. L., Jang, H. C., Park, K. S., & Cho, Y. M. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.3.192 · Cited by 37
“It was reported that more frequent measurements of blood glucose levels improved glycemic control even without IT applications [39,40].”
Backgroundda Silva, M. R. R., Diniz, L. M., dos Santos, J. B. R., Reis, E. A., da Mata, A. R., de Araújo, V. E., Álvares-Teodoro, J., & Acúrcio, F. D. A. (2018) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232018238.10222016 · Cited by 42
Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research
Schnell, O., Barnard, K., Bergenstal, R., Bosi, E., Garg, S., Guerci, B., Haak, T., Hirsch, I. B., Ji, L., Joshi, S. R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2919 · Cited by 36
Self-citationStructured self‐monitoring of blood glucose reduces glycated hemoglobin in insulin‐treated diabetes
Kato, N., Cui, J., & Kato, M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12072 · Cited by 36
Technology to Optimize Pediatric Diabetes Management and Outcomes
Markowitz, J. T., Harrington, K. R., & Laffel, L. M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0419-3 · Cited by 41
Kim, Y., Park, J.-E., Lee, B.-W., Jung, C.-H., & Park, D.-A. (2019) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x18782599 · Cited by 35
Systematic review of self-monitoring of blood glucose in patients with type 2 diabetes
Chircop, J., Sheffield, D., & Kotera, Y. (2021) · Nursing Research · doi:10.1097/nnr.0000000000000542 · Cited by 34
“In trials investigating structured SMBG versus unstructured SMBG, most participants received care in diabetes settings (Bosi et al., 2013) or primary settings (Nishimura et al., 2017; Polonsky et al., 2011) not specific to diabetes.”
BackgroundPatients who self-monitor blood glucose and their unused testing results.
Grant, R. W., Huang, E. S., Wexler, D. J., Laiteerapong, N., Warton, E. M., Moffet, H. H., & Karter, A. J. (2015) · PubMed · Cited by 37
RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India
Rao, P., Makkar, B. M., Kumar, A., Das, A. K., Singh, A. K., Mithal, A., Bhansali, A., Misra, A., Maheshwari, A., Gupta, A., et al. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0677-3 · Cited by 49
Davidson, P., Ross, T., & Castor, C. (2018) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.03.007 · Cited by 33
Breland, J. Y., McAndrew, L. M., Burns, E. A., Leventhal, E. A., & Leventhal, H. (2013) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721713490079 · Cited by 36
Lin, M., Chen, T., & Fan, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1111565 · Cited by 44
Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021
CHENG, A. Y. Y., Feig, D. S., Ho, J., Siemens, R. L., BAJAJ, H. S., Gilbert, J. D., Houlden, R. L., Kim, J., MacKay, D., Rabi, D. M., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.07.003 · Cited by 38
Blackberry, I., Furler, J., Ginnivan, L., Manski-Nankervis, J.-A. E., Jenkins, A. J., Cohen, N. D., Best, J. D., Young, D. Y. L., Liew, D., Ward, G. M., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.011 · Cited by 38
“Mild dysglycemia” in type 2 diabetes: to be neglected or not?
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.004 · Cited by 31
“An expert panel of diabetes specialists chaired by Richard Bergenstal (2013) recently recommended that the clinical decision making process in the management of persons with type 1 diabetes should be based not only on HbA1c but also on the assessment of ambulatory glucose profiles by using either discontinuous self mo…”
BackgroundInfluentialUnblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes
Ahn, D. T., Pettus, J., & Edelman, S. V. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816632241 · Cited by 31
Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach
Ceriello, A., Gallo, M., Candido, R., Esposito, K., Gnetile, S., Medea, G., & Micheli, A. D. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s50288 · Cited by 31
Blevins, T. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.05.2668 · Cited by 34
Grady, M., Katz, L. B., & Levy, B. L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818775755 · Cited by 30
Miñambres, I., Sánchez‐Quesada, J. L., Vinagre, I., et al. (2014) · Endocrine Research · doi:10.3109/07435800.2014.982326 · Cited by 28
Treating psychological insulin resistance in type 2 diabetes
Allen, N. A., Zagarins, S., Feinberg, R. G., & Welch, G. W. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.11.005 · Cited by 37
Blood Glucose Pattern Management in Diabetes: Creating Order from Disorder
Choudhary, P., Genovese, S., & Reach, G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700618 · Cited by 28
Giordanengo, A., Årsand, E., Woldaregay, A. Z., Bradway, M., Grøttland, A., Hartvigsen, G., Granja, C., Torsvik, T., & Hansen, A. H. (2019) · JMIR Diabetes · doi:10.2196/14002 · Cited by 30
“We used a standard pooled deviation for illustrating the variability of data type, considering that diabetes, as a chronic disease, is a day-to-day management disease and that a routine (ie, less variability of medical values) can improve the condition of patients drastically [62,63].”
MethodFonda, S. J., Salkind, S. J., Walker, M. S., Chellappa, M., Ehrhardt, N. M., & Vigersky, R. A. (2012) · Diabetes Care · doi:10.2337/dc12-1225 · Cited by 28
Virdi, N., Daskiran, M., Nigam, S., Kozma, C., & Raja, P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0047 · Cited by 27
Yeoh, E., Lim, B. K., Fun, S., Tong, J., Yeoh, L. Y., Sum, C. F., Subramaniam, T., & Lim, S. C. (2018) · Nephrology · doi:10.1111/nep.12978 · Cited by 27
The 2012 SEMDSA Guideline for the Management of type 2 Diabetes
(2012) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2012.10872277 · Cited by 39
Meta-analysis of telemonitoring to improve HbA1c levels: Promise for stroke survivors
Lieber, B. A., Taylor, B., Appelboom, G., Prasad, K., Bruce, S., Yang, A., Bruce, E., Christophe, B., & Connolly, E. S. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.11.009 · Cited by 25
Rodbard, H. W., Schnell, O., Unger, J. R., Rees, C., Amstutz, L., Parkin, C. G., Jelsovsky, Z., Wegmann, N., Schweitzer, M. A., & Wagner, R. S. (2012) · Diabetes Care · doi:10.2337/dc11-1351 · Cited by 26
Self-citationLi, Y., Guo, X., Xiong, Z., Lou, Q., Shen, L., Zhao, F., Sun, Z., & Li, J. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131776 · Cited by 27
Harashima, S., Fukushima, T., Sasaki, M., Nishi, Y., Fujimoto, S., Ogura, M., Yamane, S., Tanaka, D., Harada, N., Hamasaki, A., et al. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2363 · Cited by 26
Ceriello, A., Gallo, M., Armentano, V., Perriello, G., Gentile, S., & Micheli, O. B. O. T. A. A. D. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0233 · Cited by 31
Translating What Works: A New Approach to Improve Diabetes Management
Phillips, L. S., Barb, D., Yong, C., Tomolo, A. M., Jackson, S. L., Olson, D. E., Rhee, M. K., Duva, I. M., He, Q., & Long, Q. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815576000 · Cited by 25
Lalic, N. M., Lalic, K. S., Jotić, A., Stanojević, D., Živojinović, D., Janićijević, A., Parkin, C. G., & SPA-EDU Study Group (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816681323 · Cited by 24
Self-citationScavini, M., Bosi, E., Ceriello, A., Giorgino, F., Porta, M., Tiengo, A., Vespasiani, G., Bottalico, D., Marino, R., Parkin, C., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-011-0357-y · Cited by 25
Self-citationGarcía de la Torre, N., Durán, A., del Valle, L., Fuentes, M., Barca, I., Martín, P., Montañez, C., Perez-Ferre, N., Abad, R., Sanz, F., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0467-9 · Cited by 24
Lalic, N. M., Tankova, T. I., Nourredine, M., Parkin, C. G., Schweppe, U., & Amann-Zalán, I. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0186 · Cited by 25
“Formal training was conducted by an endocrinologist, using the training program and materials used in the STeP study.(8) Physicians were asked to provide training to their study patients, focusing on improvement of glycemic control through structured glucose monitoring and lifestyle adjustments (e.”
Self-citationGrady, M., Campbell, D. J., MacLeod, K., & Srinivasan, A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700419 · Cited by 24
Katz, L. B., Stewart, L., Guthrie, B., & Cameron, H. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819867396 · Cited by 24
Practical approaches for self-monitoring of blood glucose: an Asia-Pacific perspective
Chowdhury, S., Ji, L., Suwanwalaikorn, S., Yu, N.-C., & Tan, E. K. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1005832 · Cited by 27
Johansson, K., Osterberg, S., Leksell, J. K., & Berglund, M. (2016) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.3402/qhw.v11.31330 · Cited by 38
“Similarly, Kato, Cui, and Kato (2013) showed that structured self-monitoring of blood glucose increases knowledge of how the lived body reacts and awareness of the connection between food and blood sugar, leading to increased participation in treatment change (Polonsky et al., 2011).”
Raoufi, A. M., Tang, X., Jing, Z., Zhang, X., Xu, Q., & Zhou, C. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0499-9 · Cited by 31
Insulin initiation and intensification in patients with T2DM for the primary care physician
Unger, J. R. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s14653 · Cited by 22
Can patients use test results effectively if they have direct access?
O’Kane, M., Freedman, D. B., & Zikmund‐Fisher, B. J. (2015) · BMJ · doi:10.1136/bmj.h673 · Cited by 21
Sato, J., Kanazawa, A., Ikeda, F., Shigihara, N., Kawaguchi, M., Komiya, K., Uchida, T., Ogihara, T., Mita, T., Shimizu, T., et al. (2016) · Journal of International Medical Research · doi:10.1177/0300060515600190 · Cited by 22
Update on strategies limiting iatrogenic hypoglycemia
Bonaventura, A., Montecucco, F., & Dallegri, F. (2015) · Endocrine Connections · doi:10.1530/ec-15-0044 · Cited by 26
György, J., Gaál, Z., Gerő, L., Hídvégi, T., Kempler, P., Winkler, G., & Wittmann, I. (2017) · Diabetologia Hungarica · doi:10.24121/dh.2017.1 · Cited by 39
Russo, G. T., Scavini, M., Acmet, E., Bonizzoni, E., Bosi, E., Giorgino, F., Tiengo, A., Cucinotta, D., & on behalf of the PRISMA Study Group (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0358 · Cited by 21
den Braber, N., Vollenbroek-Hutten, M. M. R., Oosterwijk, M. M., Gant, C. M., Hagedoorn, I. J. M., van Beijnum, B.-J. F., Hermens, H. J., & Laverman, G. D. (2019) · Nutrients · doi:10.3390/nu11020409 · Cited by 25
“Diabetes healthcare professionals (HCPs) support patients, whereby they provide education and coaching on lifestyle and pharmacological therapy [9].”
BackgroundBailey, T. S., Chang, A., Rosenblit, P. D., Jones, L., Teft, G., Setford, S. J., & Mahoney, J. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0260 · Cited by 24
Powers, M. A., Davidson, J. L., & Bergenstal, R. M. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.2.91 · Cited by 21
Mann, J., Mohan, V., Mapari, J., Karnad, P., & Maheshwari, V. K. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_216_17 · Cited by 24
“It also provides a stimulus to the patients for a better understanding of their disease, improving medication compliance and lifestyle changes, eventually resulting in an improved glycemic control.[22] IDF and ADA also recommend regular SMBG to ensure the success of the diabetes management plan.”
BackgroundA Digital-First Model of Diabetes Care
Cafazzo, J. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0058 · Cited by 24
Postma, M. J., Boersma, C., Vandijck, D. M., et al. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.50 · Cited by 20
Schnell, O., Amann-Zalán, I., Jelsovsky, Z., Moritz, A., Bermejo, J. L., Parkin, C. G., Schweitzer, M. A., Fisher, L., & Polonsky, W. H. (2013) · Diabetes Care · doi:10.2337/dc12-1711 · Cited by 23
Self-citationSpeight, J., Browne, J. L., & Furler, J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761957 · Cited by 20
Professional flash continuous glucose monitoring as a supplement to A1C in primary care
Hirsch, I. B. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1383137 · Cited by 25
Kulzer, B., Dänschel, W., Dänschel, I., Siegel, E. G., Schramm, W., Parkin, C. G., Messinger, D., Weissmann, J., Djuric, Z., Mueller, A., et al. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815617487 · Cited by 20
Self-citationMbanya, J. C., Aschner, P. J., Chan, J. C. N., Gagliardino, J. J., & Saji, J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.029 · Cited by 22
O’Neill, M., Houghton, C., Crilly, G., & Dowling, M. (2021) · Chronic Illness · doi:10.1177/1742395320983877 · Cited by 23
“their blood sugars, however, structured self-monitoring of blood glucose improves glycaemic control and can facilitate timely and appropriate treatment changes.(49) The”
BackgroundTanaka, N., Yabe, D., Murotani, K., Ueno, S., Kuwata, H., Hamamoto, Y., Kurose, T., Takahashi, N., Akashi, T., Matsuoka, T., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12827 · Cited by 22
Nishimura, A., Harashima, S.-I., Fujita, Y., Tanaka, D., Wang, Y., Liu, Y., & Inagaki, N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.08.019 · Cited by 18
The role of blood glucose monitoring in non-insulin treated type 2 diabetes: What is the evidence?
Benhalima, K., & Mathieu, C. (2012) · Primary care diabetes · doi:10.1016/j.pcd.2012.05.001 · Cited by 20
Schnell, O., Hinzmann, R., Kulzer, B., Freckmann, G., Erbach, M., Lodwig, V., & Heinemann, L. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700619 · Cited by 21
Williams, D. M., Parsons, S. N., Dunseath, G. J., Stephens, J. W., Luzio, S. D., & Owens, D. R. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.01.006 · Cited by 20
Evans, J. M. M., Mackison, D., Swanson, V., Donnan, P. T., Emslie-Smith, A. M., & Lawton, J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.005 · Cited by 18
Lange, K., Ziegler, R., Neu, A., Reinehr, T., Daab, I., Walz, M., Maraun, M., Schnell, O., Kulzer, B., Reichel, A., et al. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1006355 · Cited by 18
Self-citationUse of self-monitoring tools in a clinic sample of adults with type 2 diabetes
Tanenbaum, M. L., Bhatt, H. B., Thomas, V. A., & Wing, R. R. (2016) · Translational Behavioral Medicine · doi:10.1007/s13142-016-0418-4 · Cited by 21
Klonoff, D. C., Zhang, J. Y., Shang, T., Mehta, C., & Kerr, D. E. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820973185 · Cited by 20
Lever, C. S., Williman, J. A., Boucsein, A., Watson, A. S., Sampson, R. S., Sergel‐Stringer, O. T., Keesing, C., Chepulis, L. M., Wheeler, B. J., de Bock, M. I., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15348 · Cited by 20
Dallosso, H. M., Bodicoat, D. H., Campbell, M., Carey, M. E., Davies, M. J., Eborall, H. C., Hadjiconstantinou, M., Khunti, K., Speight, J., & Heller, S. (2015) · Diabetic Medicine · doi:10.1111/dme.12598 · Cited by 17
Holmes-Truscott, E., Baptista, S., Ling, M., Collins, E., Ekinci, E. I., Furler, J., Hagger, V., Manski-Nankervis, J.-A., Wells, C., & Speight, J. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1177030 · Cited by 17
Evaluation of multiple drug use in patients with type 2 diabetes mellitus
İnci, H. (2021) · Diabetology International · doi:10.1007/s13340-021-00495-5 · Cited by 16
Aghili, R., Khamseh, M. E., Malek, M., Yarahmadi, S., & Farshchi, A. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-32 · Cited by 16
Ji, L., Su, Q., Feng, B., Shan, Z., Hu, R., Xing, X., Xue, Y., Yang, T., & Hua, Y. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12434 · Cited by 18
Carvalho, F. S., Netto, A. P., Zach, P. L., Sachs, A., & Zanella, M. T. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000200004 · Cited by 42
Yu-Fei, W., Wei-Ping, J., Ming-Hsun, W., Miao-O, C., Ming-Chang, H., Chi-Pin, W., & Ming-Shih, L. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817705143 · Cited by 15
Austin, M. M. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.2.83 · Cited by 15
Parsons, S. N., Luzio, S. D., Bain, S. C., Harvey, J. N., McKenna, J., Khan, A., Rice, S., Watkins, A. J., & Owens, D. R. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0154-x · Cited by 21
Schnell, O., Erbach, M., & Wintergerst, E. S. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700413 · Cited by 16
Monitoring Glycemia in Diabetes
Healy, S. J., & Dungan, K. M. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.017 · Cited by 22
Recent advances in computational tools and resources for the self-management of type 2 diabetes
Moonian, O., Jodheea-Jutton, A., Khedo, K. K., Baichoo, S., Nagowah, S. D., Nagowah, L., Mungloo-Dilmohamud, Z., & Cheerkoot-Jalim, S. (2020) · Informatics for Health and Social Care · doi:10.1080/17538157.2018.1559168 · Cited by 15
Klonoff, D. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529638 · Cited by 21
An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately
Heinemann, L., & Klonoff, D. C. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819895083 · Cited by 16
Sendekie, A. K., Dagnew, E. M., Tefera, B. B., & Belachew, E. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068518 · Cited by 21
Nauck, M. A., Haastert, B., Trautner, C., Müller, U. A., Nauck, M. A., & Heinemann, L. (2014) · Diabetologia · doi:10.1007/s00125-014-3168-1 · Cited by 17
Parkin, C. G., Hinnen, D. A., & Tetrick, D. L. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.131 · Cited by 15
Self-citationSelf-monitoring of blood glucose: Advice for providers and patients
Knapp, S., Manroa, P., & Doshi, K. B. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.14147 · Cited by 14
Alvarenga, M. A., Komatsu, W. R., de Sá, J. R., Chacra, A. R., & Dib, S. A. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0382-x · Cited by 14
Large-scale performance evaluation of Accu-Chek inform II point-of-care glucose meters
Jeong, T., Cho, E., Ko, D., Lee, W., Chun, S., Hong, K.-S., & Min, W. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2016.1233575 · Cited by 16
Alsahli, M. A., Abd-Alrazaq, A. A., Househ, M. S., Konstantinidis, S. T., & Blake, H. (2021) · Journal of Medical Internet Research · doi:10.2196/29663 · Cited by 14
“The aforementioned studies had short interventions (median 12 weeks); thus, outcomes such as weight and BMI are less likely to change on a short timescale [33].”
BackgroundSchnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600323 · Cited by 14
Dallosso, H. M., Eborall, H., Daly, H., Martin-Stacey, L., Speight, J., Realf, K., Carey, M., Campbell, M. J., Dixon, S., Khunti, K., et al. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-18 · Cited by 14
Tunis, S. L. (2011) · Applied Health Economics and Health Policy · doi:10.2165/11594270-000000000-00000 · Cited by 14
Netto, A. P., & Zanella, M. T. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0092 · Cited by 14
“In an article published in 2011, Polonsky et al.14 reported the significant results of the implementation of a structured SMBG program that did not utilize computerized resources, with the results being evaluated just with the help of graphic methods recorded by the patients in a special printed plotting card.”
BackgroundInfluential
Metadata
- Authors
- Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S.
- Affiliations
- University of California San Diego (US)
- University of California, San Francisco (US)
- Endeavor Health (US)
- Mid America Diabetes Associates, Wichita, Kansas
- Health Management Resources, Carmel, Indiana
- Biostat International, Tampa, Florida
- Roche Diagnostics, Indianapolis, Indiana
- Corresponding author
- Parkin, Christopher G.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 262-267
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024331
- OpenAlex
- W2102487069
- Semantic Scholar
- 074343a0d8101d85936aedd3d5e7285d19afe6d6
- Cited by
- 429
- References
- 26
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 20 · 2021: 27 · 2020: 21 · 2019: 26 · 2018: 28 · 2017: 25 · 2016: 47 · 2015: 37 · 2014: 31 · 2013: 44 · 2012: 43
- FWCI
- 37.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, glycemic control, HbA1c, insulin-naive patients, glycemic variability, treatment intensification, general well-being, primary care
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Patient Education as Topic, Patient Participation, Primary Health Care, Prospective Studies, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.